Development of a sample preparation and analysis method for therapeutic monitoring of diazepam and major metabolite in alcohol withdrawal syndrome treatment
 
Yazarlar (8)
Dr. Öğr. Üyesi Kenan Can Tok Ankara University, Türkiye
Doç. Dr. Selin ÖZKAN KOTİLOĞLU Kırşehir Ahi Evran Üniversitesi, Türkiye
H. Ceren Bozmaoğlu
Mustafa Danışman Ankara Training & Res Hosp AMATEM Clin
Prof. Dr. İnci İlhan Ankara Üniversitesi, Türkiye
Prof. Dr. Dilek Akyüzlü Ankara Üniversitesi, Türkiye
Doç. Dr. Mehmet Gümüştaş Ankara Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (Q2)
Dergi ISSN 0731-7085 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili Türkçe Basım Tarihi 08-2025
Cilt / Sayı / Sayfa 260 / 116805 / 116805–116805 DOI 10.1016/j.jpba.2025.116805
Makale Linki https://doi.org/10.1016/j.jpba.2025.116805
Özet
Diazepam, a widely prescribed benzodiazepine, is frequently used for the management of alcohol withdrawal syndrome, anxiety, seizures, and muscle spasms. Its monitoring is critical due to its potential for abuse and the therapeutic importance of its metabolite nordiazepam. A sustainable and environmentally friendly high-performance liquid chromatography method was developed and validated for the quantification of diazepam and its active metabolite nordiazepam in human plasma samples. The chromatographic analysis was conducted on an HPLC system equipped with a UV detector. Separation was achieved using a Kinetex F5 column (150 ×4.6 mm, 5 µm). The mobile phase consisted of acetonitrile and phosphate buffer adjusted to pH 4.3 (30:70, v/v), delivered in isocratic mode at a flow rate of 1.0 mL/min, with the pH adjusted to optimize resolution. The method demonstrated excellent sensitivity …
Anahtar Kelimeler
Diazepam | Nordiazepam | Forensic Toxicology | HPLC-UV | Method Development and Validation | Drug Monitoring